Ryan M. Schwarz is a Managing Director focused on U.S. growth capital opportunities in the healthcare sector. Mr. Schwarz leads the healthcare investing practice in the U.S. Growth Capital Group, with a particular focus on medical devices and products, healthcare information technology and selected healthcare services. He joined Carlyle in 1997 and is based in Washington, DC.

Mr. Schwarz previously served as a Vice President in the healthcare group at Robertson Stephens & Co. He was also an investment banker at Morgan Stanley & Co. Inc.

Mr. Schwarz received his J.D., magna cum laude from Harvard Law School and his M.B.A. with Distinction from Harvard Business School. He also received his A.B., magna cum laude from Duke University where he was elected Phi Beta Kappa and was an Angier B. Duke Scholar.

Mr. Schwarz is on the Board of Directors of AcuFocus, Inc., Carefx Corp., Fairchild Imaging, Inc., NeoVista, Inc., PixelOptics, Inc., Primary Health, Inc. and Proteus Biomedical, Inc. He was formerly a Director of ConnectiCare Holdings, Inc. (sold to Health Insurance Plan of Greater New York), Endius, Inc. (sold to Zimmer, Inc.), LipoSonix, Inc. (sold to Medicis Pharmaceutical Corp.) and Heritage Health Systems, Inc. (sold to Universal American Financial Corp.).

Mr. Schwarz also serves on the Boards of the Mid-Atlantic Venture Association and certain charitable not-for-profit organizations in the Washington, DC area.